ArticleStem cell research & therapy2015

Predicting poor peripheral blood stem cell collection in patients with multiple myeloma receiving pre-transplant induction therapy with novel agents and mobilized with cyclophosphamide plus granulocyte-colony stimulating factor: results from a Gruppo Italiano Malattie EMatologiche dell'Adulto Multiple Myeloma Working Party study.

Pellegrino Musto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.